GlassScriptPhysician profile
Lily Chen
NPI 1861819815
$74,266.65
in general payments reported to CMS, 2019-2025
33 companies · $1,629 in 2025
The $1,629 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,515 · 2020: $25K · 2021: $21K · 2022: $12K · 2023: $4,164 · 2024: $8,538 · 2025: $1,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,308 · Consulting Fee: $5,000 · Travel and Lodging: $2,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,307.85 |
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $2,023.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,809.43 | 2021-2024 | Micra, Onyx Frontier, Linq II |
| Medtronic Vascular, INC. | $15,146.04 | 2019-2020 | |
| Abbott Laboratories | $13,538.83 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint |
| Philips North America LLC | $9,046.91 | 2022-2024 | (9520) Igt Devices Undivided |
| Boston Scientific Corporation | $4,998.14 | 2019-2025 | Avvigo Guidance System, Synergy, Ilab Ultrasound Imaging System |
| Edwards Lifesciences Corporation | $2,165.14 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| W. L. Gore & Associates, INC. | $1,962.74 | 2019-2024 | Gore Cardioform Septal Occluder |
| Biotronik INC. | $1,898.70 | 2019-2025 | Acticor 7 Vr-T Dx, Recross, Pk Papyrus |
| Siemens Medical Solutions USA, INC. | $1,534.12 | 2022 | |
| Abiomed | $1,384.50 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,130.45 | 2019-2023 | Lifevest |
| Shockwave Medical, INC | $703.62 | 2020-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $374.92 | 2019-2023 | Kengreal |
| Amgen INC. | $346.51 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $259.79 | 2019-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $235.79 | 2021-2023 | Asahi Ptca Guide Wire |
| Atricure, INC. | $227.54 | 2024 | |
| Inari Medical, INC. | $196.97 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $192.82 | 2019-2025 | |
| Teleflex LLC | $170.12 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $155.65 | 2019-2025 | Camzyos, Eliquis |
| Cathworks, INC. | $143.19 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $93.66 | 2019-2025 | Farxiga, Wainua |
| Penumbra, INC. | $92.82 | 2025 | Indigo System |
| Regeneron Healthcare Solutions, INC. | $89.68 | 2019 | |
| Sanofi-Aventis U.S. LLC | $76.99 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $76.26 | 2023-2025 | Verquvo, Capvaxive |
| Inspire Medical Systems, INC. | $58.91 | 2024 | Inspire |
| Alnylam Pharmaceuticals INC. | $43.32 | 2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $32.91 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $30.00 | 2020 | |
| Esperion Therapeutics, INC. | $29.35 | 2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lily Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.